Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Assertio (ASRT) stocks in Canada
Learn how to easily invest in Assertio stocks.
Assertio is a drug manufacturers-specialty & generic business based in the US. Assertio stocks (ASRT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.62 – an increase of 13.59% over the previous week. Assertio employs 27 staff and has a trailing 12-month revenue of around $109.7 million.
How to buy shares in Assertio
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ASRT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Assertio?
- Has coronavirus impacted Assertio shares?
- Assertio shares summary
- Compare share dealing platforms
- Is Assertio stock a buy or sell?
- Assertio performance over time
- Assertio's financials
- How volatile are Assertio shares?
- Does Assertio pay a dividend?
- Have Assertio shares ever split?
- Other common questions
Assertio stock price (NASDAQ:ASRT)Use our graph to track the performance of ASRT stocks over time.
Assertio shares at a glance
|Latest market close||$2.34|
|52-week range||$0.85 - $5.80|
|50-day moving average||$1.88|
|200-day moving average||$1.52|
|Wall St. target price||$4.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.78|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Assertio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Assertio price performance over time
|1 week (2022-01-21)||13.59%|
|1 month (2021-12-29)||21.24%|
|3 months (2021-10-29)||127.18%|
|6 months (2021-07-29)||78.63%|
|1 year (2021-01-29)||271.13%|
|2 years (2020-01-29)||110.81%|
|3 years (2019-01-29)||4.22|
|5 years (2017-01-27)||17.96|
Is Assertio under- or over-valued?
Valuing Assertio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Assertio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Assertio's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $34.1 million.
The EBITDA is a measure of a Assertio's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$109.7 million|
|Operating margin TTM||4.92%|
|Gross profit TTM||$92.3 million|
|Return on assets TTM||1.07%|
|Return on equity TTM||-35%|
|Market capitalisation||$95 million|
TTM: trailing 12 months
Assertio share dividends
We're not expecting Assertio to pay a dividend over the next 12 months.
Have Assertio's shares ever split?
Assertio's shares were split on a 1:4 basis on 17 May 2021. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Assertio shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Assertio shares which in turn could have impacted Assertio's share price.
Assertio share price volatility
Over the last 12 months, Assertio's shares have ranged in value from as little as $0.85 up to $5.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Assertio's is 1.664. This would suggest that Assertio's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Assertio Holdings, Inc. , a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. The company's pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, an NSAID for relief of mild to moderate acute pain; and SPRIX, an NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020.
Stocks similar to Assertio
Assertio in the news
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
Stocks making the biggest moves midday: Netflix, Kohl's, Wynn Resorts, General Motors and more
RBC upgrades Comcast to outperform on subscriber growth
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.